HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

Market Cap	143.70B
Revenue (ttm)	121.17B
Net Income (ttm)	7.76B
Shares Out	30.00M
EPS (ttm)	258.54
PE Ratio	18.53
Forward PE	8.45
Dividend	35.00 (0.73%)
Ex-Dividend Date	Dec 27, 2024

Volume	46,854
Average Volume	125,587
Open	4,780.00
Previous Close	4,750.00
Day's Range	4,670.00 - 4,820.00
52-Week Range	3,865.00 - 12,630.00
Beta	0.52
RSI	57.06
Earnings Date	Feb 4, 2025

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd. engages in the manufacture and sale of natural materials for cosmetics, nutraceuticals, and regenerative medicines worldwide. The company’s cosmetics includes whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products; and functional food ingredients comprising various nutraceuticals and general food raw ingredients. It is also involved in the provision of medical biomedical materials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supply of active ...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 320
• Stock Exchange: KOSDAQ
• Ticker Symbol: 052260

Financial Performance

In 2023, HYUNDAI BIOLAND's revenue was 101.69 billion, an increase of 2.56% compared to the previous year's 99.15 billion. Earnings were 8.06 billion, an increase of 69.09%.